Patents by Inventor Linda M. Lynch

Linda M. Lynch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6887863
    Abstract: Compounds having the formula are methionine aminopeptidase type 2 (MetAP2) inhibitors and are useful for inhibiting angiogenesis. Also disclosed are MetAP2-inhibiting compositions and methods of inhibiting angiogenesis in a mammal.
    Type: Grant
    Filed: February 19, 2004
    Date of Patent: May 3, 2005
    Assignee: Abbott Laboratories
    Inventors: Richard A. Craig, Megumi Kawai, Linda M. Lynch, Jyoti R. Patel, George S. Sheppard, Jieyi Wang, Fan Yang, Nwe Ba-Maung, Xenia Beebe Searle
  • Publication number: 20040167126
    Abstract: Compounds having the formula 1
    Type: Application
    Filed: February 19, 2004
    Publication date: August 26, 2004
    Inventors: Richard A. Craig, Megumi Kawai, Linda M. Lynch, Jyoti R. Patel, George S. Sheppard, Jieyi Wang, Fan Yang, Nwe Ba-Maung, Xenia Beebe Searle
  • Publication number: 20020049223
    Abstract: Compounds having formula (I) 1
    Type: Application
    Filed: May 7, 2001
    Publication date: April 25, 2002
    Inventors: Steven W. Elmore, Curt S. Cooper, Colleen C. Schultz, Douglas K. Hutchinson, Pamela L. Donner, Brian E. Green, David D. Anderson, Qinghua Xie, Jurgen Dinges, Linda M. Lynch, John K. Pratt
  • Publication number: 20020002152
    Abstract: Compounds having the formula 1
    Type: Application
    Filed: April 12, 2001
    Publication date: January 3, 2002
    Inventors: Richard A. Craig, Megumi Kawai, Linda M. Lynch, Jyoti R. Patel, George S. Sheppard, Jieyi Wang, Fan Yang, Nwe Ba-Maung
  • Patent number: 6242494
    Abstract: A class of substituted b-amino acids are potent inhibitor of methionine aminopeptidase type 2 (MetAP2) and are thus useful in inhibiting angiogenesis and disease conditions which depend upon angiogenesis for their development such as diabetic retinopathy, tumor growth, and conditions of inflammation. Pharmaceutical compounds containing the compounds and methods of inhibiting methionine aminopeptidase-2, and angiogenesis are also disclosed.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: June 5, 2001
    Assignee: Abbott Laboratories
    Inventors: Richard A. Craig, Jack Henkin, Megumi Kawai, Linda M. Lynch, Jyoti Patel, George S. Sheppard, Jieyi Wang